[A proposed open formulary for a managed care program in Mexico. The Therapeutic and Pharmacological Committee of Mexico].
To integrate an open formulary with drug use recommendations in which a physician could find a wide range of therapeutic options for his private practice. An interdisciplinary medical committee with a high scientific level, reviewed each one of all the drugs available to be sell in Mexico, as part of a Pharmacy Benefit Management & Manage Care program implemented in our country. Each drug was classified according to its active ingredient under one of the following categories: 1) essentials, 2) excluded, and 3) not essentials-not excluded. The decision in each case was based on pure scientific grounds and using an Evidence-Based Medicine analysis. The proposed formulary contains a total of 1106 active ingredients-either unique or in combination-, from which 429 (38.8%) were classified as essentials. About one-out-of-ten drugs (8.7%) currently in use within the private medical practice in Mexico, some of them highly prescribed, were regarded by the committee as excluded due to concerns about their efficacy and/or safety. On this report a detailed description of the process followed to conform the committee, its objectives an its performing criteria is presented, as well as the bases under which the final list of drugs of the formulary were set.